Erschienen in:
01.06.2018 | Neuromuscular Blockade (GS Murphy, Section Editor)
Quantitative Neuromuscular Monitoring: Current Devices, New
Technological Advances, and Use in Clinical Practice
verfasst von:
Hajime Iwasaki, Reka Nemes, Sorin J. Brull, J. Ross Renew
Erschienen in:
Current Anesthesiology Reports
|
Ausgabe 2/2018
Einloggen, um Zugang zu erhalten
Abstract
Purpose of Review
The purpose of this review is to summarize various quantitative
neuromuscular monitoring modalities and describe strategies to implement them
into routine practice. We will contrast these objective modalities with
unreliable clinical tests and subjective techniques that expose patients to
unnecessary risk associated with postoperative residual weakness.
Recent Findings
As major specialty societies publish guidelines and consensus
statements urging anesthesiologists to utilize quantitative monitors, clinicians
must familiarize themselves with this equipment. Furthermore, new monitors are
emerging as the industry tries to address the need for user-friendly, reliable
monitors.
Summary
Clinical assessment is an unacceptable technique to guide
neuromuscular blockade management in patients receiving neuromuscular blocking
agents. The use of a peripheral nerve stimulator can provide some information
regarding the level of neuromuscular blockade in patients; however, it cannot
reliably confirm adequate recovery. The use of objective, quantitative
monitoring is an essential practice that helps guide the administration of
neuromuscular blocking agents and excludes deleterious postoperative residual
weakness.